Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions

The Lancet

Volumn 344, Issue 8935, 1994, Pages 1510-1511

  Majewski, Slawomir ^a,b   Skopinska, Magdalena ^a,b   Bollag, Werner ^a,b   Jablonska, Stefania ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Pharma Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; CALCITRIOL; COLECALCIFEROL DERIVATIVE; ISOTRETINOIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; CASE REPORT; CLINICAL TRIAL; ERYTHEMA; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN CANCER; SKIN DEFECT; XEROSIS;

EID: 0027985108     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90330-1     Document Type: Letter

References (4)

1. Biological interactions of retinoids with cytokines and vitamin D analogs as a basis for cancer combination chemotherapy
2. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
3. Acute promyelocytic leukemia
4. Alfacalcidol is a nontoxic effective treatment of follicular small-cleaved cells lymphoma